VAERS reports by lot

GSK DTaP/Tdap lot 7HM5J: VAERS reports

32 VAERS reports list lot 7HM5J as a GSK DTaP/Tdap vaccine, received between 2023-03-24 and 2024-12-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
32
Reports
3%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2045%
General / Systemic (non-local)716%
Neurological511%
Allergic / Anaphylactic49%
Gastrointestinal49%
Psychiatric / Neuropsychiatric37%
Dermatological (non-injection-site)12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California3
Kentucky3
Indiana3
Florida2
Michigan2
Washington2
Pennsylvania2
Tennessee1
Arizona1
Arkansas1
Oregon1
Missouri1

Reports by month received

2023-032
2023-042
2023-053
2023-063
2023-084
2023-103
2023-112
2024-011
2024-024
2024-031
2024-051
2024-083
2024-101
2024-111
2024-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.